308 / 330
REPORT OF THE BOARD OF DIRECTORS AND DRAFT RESOLUTIONS TO BE PRESENTED AT THE COMBINED SHAREHOLDERS’ MEETING OF MAY 10, 2017
6.3 Summary table of financial authorizations currently in force or submitted for approval
6
308
Registration Document 2016 — Capgemini
Use of authorizations during 2016
price of €81.18. As part of the Liquidity contract 2,686,396 shares
buyback program (excluding the Liquidity contract) at an average
2,621,396 shares were sold at an average market price of €81.33.
were purchased at an average price of €81.12 and
150,000 shares and about €9 million.
The balance of the Liquidity contract on December 31, 2016 is
Shareholders’ Meeting of May 18, 2016 in the tenth resolution, the
Pursuant to the authorization granted by the Ordinary
Board of Directors purchased 4,128,337 shares under the share
Shareholders’ Meeting of May 18, 2016 in the eleventh resolution,
Pursuant to the powers conferred on it by the Extraordinary
617,235 shares with a value of €50,129,800.47.
the Board of Directors in its meeting of July 26, 2016 cancelled
In addition and pursuant to the authorization granted by the
twenty-first resolution, the Board of Directors decided on July 26,
Extraordinary Shareholders’ Meeting of May 18, 2016 in the
1,175 beneficiaries (managers and employees of French and
2016 the issue of 1,663,500 performance shares to
including the Chairman and Chief Executive Officer).
foreign subsidiaries, members of the Executive Committee